Navigation Links
DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC

MIAMI, FL -- (MARKET WIRE) -- July 06, 2007 -- DOR BioPharma, Inc. (OTCBB: http://studio.financialcontent.com/Engine?Account=iwire&PageName=QUOTE&Ticker=DORB">DORB) ("DOR" or the "Company") announced today that the European Patent Office has granted a patent, EP 1024827 B1, with claims related to oral vaccination using mutated non-toxic forms of botulinum neurotoxin as a vaccine to prevent exposure to botulinum toxin. The European patent follows the issuance of a patent in the United States, U.S. 6,051,239, which was granted in April, 2000 and contains equivalent claims for oral vaccination. DOR has exclusively licensed these issued patents and related patent applications from Thomas Jefferson University.

Both the newly issued European patent and the formerly issued United States patent stem from the work of Dr. Lance Simpson at Thomas Jefferson University demonstrating that mutated forms of botulinum toxin can be administered orally to induce protective immunity to natural toxin exposure. The claims in the granted European patent provide protection for the use of certain non-toxic mutants of botulinum toxin that are capable of translocation from the gut to the general circulation for preparation of an oral vaccine.

"The grant of the European patent describing the underlying technology is an additional milestone that reinforces our patent portfolio in botulinum vaccines," said Christopher J. Schaber, PhD, President and CEO of DOR. "We also have applications in both the US and other key jurisdictions that cover additional features of BT-VACC™. We believe that oral vaccination will provide advantages over injectable botulinum vaccines because of ease of administration and rapid distribution which can facilitate mass inoculations in time of need. We hope to
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
2. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
3. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:8/19/2014)... Luoxis Diagnostics, Inc. , a ... MKT: AMPE), today announced an upcoming presentation at ... American Academy of Surgical Trauma (AAST) and Clinical ... Philadelphia, Pennsylvania that will be held ... from a recently completed five-year prospective clinical trial ...
(Date:8/19/2014)... 19, 2014 According to a ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic Navigation ... and Forecast, 2014 - 2020", the global surgical navigation ... 2013 and is expected to grow at a CAGR ... estimated value of USD 295.5 million in 2020. ...
(Date:8/18/2014)... 2014 Elbit Imaging Ltd. ("EI" ... announced today that Elbit Medical Technologies Ltd. ("Elbit Medical") ... it holds approximately 86% of the voting power, announced ... which Elbit Medical holds approximately 30.8% of the voting ... Cell,s shareholders (including Elbit Medical), signed Option and Investment ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company 3
(Date:8/20/2014)... WA (PRWEB) August 20, 2014 No matter ... always count on a steady set of friends to be ... when it comes to the concept of making new ... by various responsibilities ranging from taking care of one’s family ... comes with talking to a new person just is not ...
(Date:8/20/2014)... 2014 Building on growing success ... predicted stage iii and iv pressure ulcers with ... approached 90%. A company spokesperson commented that these ... or academic settings. The resulting capabilities can be ... hospital-acquired conditions to help providers avoid financial losses ...
(Date:8/20/2014)... “Have you recently been involved in an ... injury lawyer serving the greater Seattle area. “Are you still ... then keep reading . , In a recently released article, ... auto accident can use to see if they may qualify ... injury insurance claim will allow an individual to receive medical ...
(Date:8/20/2014)... 2014 Ticketability.com has Theresa ... fair prices. The well-known medium has been thrilling many ... touring in 19 cities, with tickets becoming available August ... will visit are Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, ... Hills and San Diego. The medium’s fans can obtain ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 BuyCheapTicketsToEvents.com ... a wide selection of tickets to many events. Cheap NHL ... will begin in September. , Hockey fans are enthusiastic about ... obtain tickets for games. Now is the time to acquire ... begin in mere months. There will be a great deal ...
Breaking Medicine News(10 mins):Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2Health News:Jvion Achieves Benchmark Accuracy in Pressure Ulcer Prediction 2Health News:Five Questions to Determine Who Qualifies for a Personal Injury Claim Recently Released by The Jones Firm in Recent Article 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:2014 NHL Preseason Tickets Are Among Top Selling Seats at Trusted Provider BuyCheapTicketsToEvents.com 2
... Clinton has once again lent a helping hand to HIV/ ... government and drug giant Merck over pricey anti-retroviral drugs, ... a deal with two Indian pharmaceutical companies Cipla and Matrix, ... second-line AVR drugs and a next generation one-pill-a-day drug. ...
... the potency of platinum-based cancer drugs when administered together to ... with tumors, scientists from Dana-Farber Cancer Institute report. ... halted or shrank mouse tumors as much as three times ... to the article in the May issue of Cancer Cell. ...
... be one way of treating diseases such as epilepsy ... seem to have pitched upon a protein that could do ... amount of information transmitted to cells. ,And so ... the key to tackling diseases such as epilepsy and schizophrenia, ...
... clinical study that relates the collapse of the trade center ... of dust and pollutants during the rescue operation. The rescuers ... which showed up a year after the catastrophe. ... Einstein College of Medicine found that 13 firefighters and emergency ...
... fruit, vitamins and minerals, and ate less fat , salt and ... these , stood to gain not in terms of weight ... the effects of 100% juice consumption on weight, has dispelled any ... health survey conducted from 1999 to 2002 and studying about 3,600 ...
... have more sleep problems than children from middle class ... school, according to research. ,The study compared ... who were African American and Hispanic, to the sleeping ... children were 4 to 10 years old. Parents were ...
Cached Medicine News:Health News:Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 3Health News:British Scientists Discover New Protein to Treat Epilepsy and Schizophrenia 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: